SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001178913-24-001095
Filing Date
2024-03-26
Accepted
2024-03-26 16:57:45
Documents
103
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A zk2431202.htm   iXBRL 20-F/A 3237983
2 EXHIBIT 2.1 exhibit_2-1.htm EX-2.1 180148
3 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 11737
4 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 12318
5 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5893
6 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5821
7 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 3758
13 GRAPHIC image0.jpg GRAPHIC 12610
14 GRAPHIC image1.jpg GRAPHIC 234850
15 GRAPHIC image00002.jpg GRAPHIC 34707
  Complete submission text file 0001178913-24-001095.txt   14052931

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE blrx-20231231.xsd EX-101.SCH 113046
9 XBRL CALCULATION FILE blrx-20231231_cal.xml EX-101.CAL 65523
10 XBRL DEFINITION FILE blrx-20231231_def.xml EX-101.DEF 258608
11 XBRL LABEL FILE blrx-20231231_lab.xml EX-101.LAB 893135
12 XBRL PRESENTATION FILE blrx-20231231_pre.xml EX-101.PRE 448452
106 EXTRACTED XBRL INSTANCE DOCUMENT zk2431202_htm.xml XML 2972448
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-35223 | Film No.: 24784437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)